Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FAM63A | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | PEX11B | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | CDC42SE1 | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-06 |
mRNA | TIMM17A | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
mRNA | LYL1 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
mRNA | NFE2 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | NBPF15 | CTRPv2 | pan-cancer | AAC | -0.17 | 8e-06 |
mRNA | STAT5A | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | RPL7 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | BMP1 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |